Cargando…
Immunotherapy for tuberculosis: future prospects
Tuberculosis (TB) is still a major global health problem. A third of the world’s population is infected with Mycobacterium tuberculosis. Only ~10% of infected individuals develop TB but there are 9 million TB cases with 1.5 million deaths annually. The standard prophylactic treatment regimens for la...
Autores principales: | Abate, Getahun, Hoft, Daniel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970630/ https://www.ncbi.nlm.nih.gov/pubmed/27529060 http://dx.doi.org/10.2147/ITT.S81892 |
Ejemplares similares
-
BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity
por: Abate, Getahun, et al.
Publicado: (2019) -
Oncolytic virus immunotherapy: future prospects for oncology
por: Raja, Junaid, et al.
Publicado: (2018) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009) -
Current applications and future prospects of nanotechnology in cancer immunotherapy
por: Yan, Sen, et al.
Publicado: (2019)